Get 20% Free Customization In This Report

Buy this report from - $3456

Hemodialysis and Peritoneal Dialysis Market by Type {Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, and Nocturnal Hemodialysis), and Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD), and Automated Peritoneal Dialysis (APD))}, Product {Device (Machine, Dialyzer, Water Treatment System, and Others), and Consumables (Bloodline, Concentrates, Catheters, and Others)}, and End Use (Home-based Dialysis, and Hospital-based Dialysis) - Global Opportunities and Forecasts, 2017-2023

Medical Devices & Supplies	LI_183474	Pages: NA	May 2018 \| 678 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Hemodialysis and peritoneal dialysis is an essential treatment for people who suffer from chronic kidney disease and acute kidney injury. Both hemodialysis and peritoneal dialysis procedures assist the kidneys to filter and remove waste & extra fluid from the body. Hemodialysis helps remove wastes such as urea from the blood, along with maintaining proper balance of electrolytes in the blood using a special filter called an artificial kidney. Peritoneal dialysis procedures utilize the lining of the abdomen to filter the blood in people who suffer from kidney failures.

The major factors that fuel the growth of the market are increasing number of final stage renal disease patients along with the increasing prevalence of diabetes and hypertension globally. In addition, transition from kidney transplantation to regular dialysis procedures and increasing investments by market players to develop new hemodialysis products leads to the market growth. However, risks and complications associated with both the dialysis procedures along with unstable reimbursement policies restrain the growth of the hemodialysis and peritoneal dialysis market. Moreover, untapped regions and technological advancements in hemodialysis and peritoneal dialysis procedures will offer profitable opportunities for the growth of the hemodialysis and peritoneal dialysis market.

The report segments the market on the basis of product, type, end user, and region. Based on type, the market is divided into hemodialysis and peritoneal dialysis. Based on product, the market is classified into device and consumables. Based on end use the market is divided into home-based dialysis and hospital-based dialysis. Based on region, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players profiled in this market are Fresenius Medical Care AG & Co. KGaA, NIPRO Medical Corporation, B. Braun Avitum AG, Baxter International, Inc., Diaverum Deutschland GmbH, Nikkiso Co. Ltd., NxStage Medical, Inc., Asahi Kasei Corporation, Medicators, Inc., and DaVita Inc.

Key Benefits

The study provides an in-depth analysis of the global hemodialysis and peritoneal dialysis market, with current trends and future estimations to elucidate imminent investment pockets.
It presents a quantitative analysis from 2016 to 2023 to enable stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of the market by type assists in understanding various forms of hemodialysis and peritoneal dialysis products available.
Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.

Hemodialysis And Peritoneal Dialysis Market Key Segmentation:

By Type

Hemodialysis
- Conventional Hemodialysis
- Short Daily Hemodialysis
- Nocturnal Hemodialysis
Peritoneal Dialysis
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Automated Peritoneal Dialysis (APD)

By Product

Device
- Machine
- Dialyzer
- Water Treatment System
- Others
Consumables
- Bloodline
- Concentrates
- Catheters
- Others

By End Use

Home-based Dialysis
Hospital-based Dialysis

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Argentina
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. HEMODIALYSIS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.2.3.1. Conventional Hemodialysis

4.2.3.1.1. Market size and forecast

4.2.3.2. Short Daily Hemodialysis

4.2.3.2.1. Market size and forecast

4.2.3.3. Nocturnal Hemodialysis

4.2.3.3.1. Market size and forecast

4.3. PERITONEAL DIALYSIS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.3.3.1. Continuous Ambulatory Peritoneal Dialysis (CAPD)

4.3.3.1.1. Market size and forecast

4.3.3.2. Automated Peritoneal Dialysis (APD)

4.3.3.2.1. Market size and forecast

Chapter: 5 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. DEVICE

5.2.1. Key market trends

5.2.1.1. Machine

5.2.1.1.1. Market size and forecast

5.2.1.2. Dialyzer

5.2.1.2.1. Market size and forecast

5.2.1.3. Water Treatment System

5.2.1.3.1. Market size and forecast

5.2.1.4. Others

5.2.1.4.1. Market size and forecast

5.3. CONSUMABLES

5.3.1. Key market trends

5.3.1.1. Bloodline

5.3.1.1.1. Market size and forecast

5.3.1.2. Concentrates

5.3.1.2.1. Market size and forecast

5.3.1.3. Catheters

5.3.1.3.1. Market size and forecast

5.3.1.4. Others

5.3.1.4.1. Market size and forecast

Chapter: 6 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USE

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOME-BASED DIALYSIS

6.2.1. Market size and forecast

6.3. HOSPITAL-BASED DIALYSIS

6.3.1. Market size and forecast

Chapter: 7 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION

7.1. OVERVIEW
7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.2.4. North America Hemodialysis and Peritoneal Dialysis Market by Type
7.2.5. North America Hemodialysis and Peritoneal Dialysis Market by Product
7.2.6. North America Hemodialysis and Peritoneal Dialysis Market by End Use

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Spain market size and forecast
7.3.3.5. Rest of Europe market size and forecast

7.3.4. Europe Hemodialysis and Peritoneal Dialysis Market by Type
7.3.5. Europe Hemodialysis and Peritoneal Dialysis Market by Product
7.3.6. Europe Hemodialysis and Peritoneal Dialysis Market by End Use

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. Rest of Asia-Pacific market size and forecast

7.4.4. Asia-Pacific Hemodialysis and Peritoneal Dialysis Market by Type
7.4.5. Asia-Pacific Hemodialysis and Peritoneal Dialysis Market by Product
7.4.6. Asia-Pacific Hemodialysis and Peritoneal Dialysis Market by End Use

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. South Africa market size and forecast
7.5.3.5. Rest of LAMEA market size and forecast

7.5.4. LAMEA Hemodialysis and Peritoneal Dialysis Market by Type
7.5.5. LAMEA Hemodialysis and Peritoneal Dialysis Market by Product
7.5.6. LAMEA Hemodialysis and Peritoneal Dialysis Market by End Use

Chapter: 8 COMPANY PROFILES

8.1. FRESENIUS MEDICAL CARE AG & CO. KGAA

8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments

8.2. NIPRO MEDICAL CORPORATION

8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments

8.3. B. BRAUN AVITUM AG

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.4. BAXTER INTERNATIONAL, INC.

8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. DIAVERUM DEUTSCHLAND GMBH

8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments

8.6. NIKKISO CO. LTD.

8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. NXSTAGE MEDICAL, INC.

8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments

8.8. ASAHI KASEI CORPORATION

8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments

8.9. MEDICATORS, INC.

8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments

8.10. DAVITA INC.

8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.